We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Heiq Plc | LSE:HEIQ | London | Ordinary Share | GB00BN2CJ299 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.50 | 4.50 | 5.50 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 62.32M | -20.84M | -0.1236 | -0.36 | 7.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/4/2023 15:37 | Another well known tip sheet's red hot tip bites the dust. | pugugly | |
27/4/2023 15:35 | Well done Dr B - Are you cancelling your subscription to SW? | pugugly | |
27/4/2023 15:30 | Management credibility here is zero. I took a 25% hit at 110p, could have been worse. | dr biotech | |
27/4/2023 15:30 | never trust the swiss. been totally done here. | edwardt | |
27/4/2023 15:24 | Another Amati failure. | toffeeman | |
27/4/2023 15:22 | Wow! Suspension for odd reasons. Shavian, that post aged well. | kemche | |
27/4/2023 15:16 | Farrugia:> Company looks very leaky or some people have magic crystal balls or gyppy tummies. Will be very interesting to see the results when thy are published unless a vulture swoops first. | pugugly | |
27/4/2023 15:08 | so someone knew that the suspension is coming? | farrugia | |
27/4/2023 15:01 | that doesn't look good - suspension | davemac3 | |
27/4/2023 10:45 | Yet again another year breakout down - Looks as though an institution may be bailing out and possibly motivating PI's to cut their losses. Management (imo) have been and maybe still are over confident in how quickly trade and consumers, in these reduced disposable income times, will be to adopted new and "improved" fabrics. Personally cannot see any reason for the share price fall to reverse until the company can demonstrate that is becoming cash flow positive and/or has substantially stopped bleeding cash. I believe there is some valuable IP within the company so it might soon appear on the radars of vulture funds looking for a low entry point. However how much further will the share price have to fall to trigger a bid or stake building. Carlo's buys in January now well under water - Just goes to show insiders often no better judges on timing than outsiders. Recent share price pressure might also be selling by Tarn-Pure recipients of the some "455,435 new ordinary shares of 30p each in the Company (the "Consideration Shares") to the vendors, issued at a price of 69.6p per share" to stop their losses as they are now at a significant discount compared to the "significant premium to then current share" at which they were issued. as part of the purchase price for Tarn. If so this sends its own message. | pugugly | |
26/4/2023 07:55 | Lots of 100k Volume selling Off Book the last days. Is somebody selling em all? | unluckyluke | |
20/4/2023 17:04 | Hedghog100: Last sentence> Sitting on the fence or possibly more painfully on your spines !! ?? However a good analysis: I would also suggest from trade knowledge that it takes very much longer and much more investment in all types of marketing and promotion to get the Trade and Consumers aware of and enthusiastic about the benefits of new fibres and fibre additives. Put it another way - Management appear to have thought they had developed a better type of mouse trap (which from their presentations they have) but it is not being adopted for a number of reasons as fast as they expected. A significant reason (imo) in above paragraph. | pugugly | |
20/4/2023 16:04 | How often are sell notes issued on c. £30M. cap. companies? Sellers are probably just using their own judgement. The 4th. January HEIQ RNS was an appalling profit warning, both in terms of the downgrade & the lateness. - Up to 70% less Q4 demand is shocking. And the forecast retention seemed to be based on little other than blind hope; which is a warning to be sceptical of HEIQ's forecasts, & indeed those of others. The HEIQ problems:- • Retail spending has been hit hard in Q4 2022: this was when soaring energy prices really started to hit people. - Much of HEIQ's income seems to be directly linked to retail sales. - Its products go into premium products, which are more discretionary. • Relatively recent China lockdowns hit sales. • Customers previously increasing their inventory because of supply chain problems has hit demand as this 'unwinds', & must have artificially inflated demand previously. - HEIQ doesn't supply end users. • Partners reluctant to sign new deals in the negative environment. • Cost inflation (although unstated) has probably also been a problem. My HEIQ prognosis:- • Potentially could have four bad quarters in 2023, v. just the one in 2022. • Potentially could run out of money. • Market won't believe the 2023 forecast until post year end trading update early 2024. • Significant director buying could be motivated mainly by trying to help his existing large shareholding. • Potentially could fall to as low as c. 10p (potentially a fundraising price) by about the turn of the year. But it could then potentially be a good investment. | hedgehog 100 | |
19/4/2023 03:18 | "Guesses or knowledge?" Nervousness as nearing the Full Year Results {28 April last year} IMHO. | piedro | |
18/4/2023 16:22 | Falling out of bed. OK Not Credit Swisse - However could bad news be leaking OR just uncertainty over Swiss Companies after Risk Management Blindness at Credit Swisse OR - Is there as SELL note out there? OR Just over exuberance when launched being further unwound as now market cap below some Institution's limit so they have to sell driving the price down further in the absence of any buyers? Guesses or knowledge? | pugugly | |
24/3/2023 18:56 | edwardt: - Fair comment - Maybe good chemists but not sure about their marketing skills. Swiss Central Bank will not ride to their rescue as would only be a rounding error compared to CS. | pugugly | |
24/3/2023 16:19 | Full Year Results were in April last year. :-) | piedro | |
24/3/2023 16:07 | somewhat lacking in newsflow here! tempted to move on and lick my considerable wounds! | edwardt | |
10/3/2023 19:15 | American Textile Company introduces bedding products with ground-breaking HeiQ Allergen* Techhttps://www.prne | livewireplus | |
07/3/2023 14:21 | no doubt they feel the shares will go up ! | haroldthegreat | |
07/3/2023 10:28 | Interims were released on 13th Sept, as pointed out by other posters leaving a TU and profit warning to Jan 4th when details must have been known a lot sooner needs justification. Tarn-Pure owners having taken paper at 69p effectively saw their investment halve on the day of announcement. | 1pencil | |
06/3/2023 19:51 | i decided to buy the shares because the Queen was using their fabric . The Queen's go-to designers Cornelia James has come to our rescue and put an end to countless searches for gloves that will protect us amid COVID-19 but are still stylish. Wherever she goes, Her Majesty always wears a pair of beautiful gloves designed by the luxury fashion house, so we imagine she was one of the first to get her hands on Cornelia James' new pair, which are made with antiviral technology HeiQ Viroblock. Shame they did not get much publicity . Their masks are pleasant to wear as well . | haroldthegreat | |
06/3/2023 10:58 | Today's volume (so far) similar to consideration shares. If correct that's over 50% down from Jan 23 issue price? "Further to the Company's announcement released on 4 January 2023, HeiQ will pay a total consideration of approximately £0.85m. Including closing adjustments to the consideration and repayments of debts, the Company will pay £530,000 in cash with the balance to be satisfied through the issuance of 455,435 new ordinary shares" | 1pencil | |
04/2/2023 15:29 | Plenty of companies in the cellulosic area but not offering the sort of product and process that matches AeoniQ. | geraldus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions